Your browser doesn't support javascript.
loading
Industrialization condition and development strategy of Paridis Rhizoma / 中草药
Chinese Traditional and Herbal Drugs ; (24): 4809-4815, 2020.
Article Dans Chinois | WPRIM | ID: wpr-846189
ABSTRACT
As an important Chinese medicinal material in China, Paridis Rhizoma has obvious curative effect and has analgesic, hemostasis, anti-inflammatory and anti-tumor activities. At present, it is the main raw material of 262 kinds of Chinese patent medicines such as Yunnan Baiyao and Gongxuening Capsule, and has important economic and social value in the Chinese medicine industry. The author mainly systematically summarizes the medicinal history and origin changes of Paridis Rhizoma, the history of industrial development, the status quo of ethnic and folk applications, the status quo of development and application of proprietary Chinese medicines, and the study of resource ecology and breeding, and proposes the implementation of the process of industrialization of Paridis Rhizoma. Important issues and countermeasures need to be paid attention in order to provide reference for the sound development of Paridis Rhizoma.

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) langue: Chinois Texte intégral: Chinese Traditional and Herbal Drugs Année: 2020 Type: Article

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Texte intégral: Disponible Indice: WPRIM (Pacifique occidental) langue: Chinois Texte intégral: Chinese Traditional and Herbal Drugs Année: 2020 Type: Article